Publication date: Available online 29 January 2017
Source:Autoimmunity Reviews
Author(s): Maria G. Tektonidou, Evrydiki Kravvariti, George Konstantonis, Nicholas Tentolouris, Petros P. Sfikakis, Athanasios Protogerou
ObjectiveAlthough a high risk of clinical and subclinical atherosclerosis has been reported in systemic lupus erythematosus (SLE), it is not directly compared with that observed in other rheumatic and non-rheumatic high-cardiovascular (CVD) risk diseases, such as Rheumatoid Arthritis (RA) and Diabetes Mellitus (DM). Our objective was to evaluate the relative risk (RR) of subclinical atherosclerosis in SLE, RA and DM patients compared to healthy controls, and examine potential associations with traditional and disease-related CVD risk factors in SLE.MethodsWe examined for atherosclerotic plaques 460 individuals (92% female) without CVD history, using carotid and femoral artery ultrasound: 115 SLE patients and matched 1:1 for age and gender RA, DM, and control subjects. Multivariate models were used to determine relative risk estimates for the number of atherosclerotic plaques in patient groups versus controls, and associations of plaques with traditional CVD and disease-related factors in SLE.ResultsA nearly two-fold higher number of atherosclerotic plaques in the carotid and femoral arteries was detected in each of SLE, RA and DM groups compared to controls, after adjusting for the effect of traditional CVD risk factors (RR=1.80, 95% CI 1.05–3.08, p=0.033, RR=1.90 (1.11–3.26), p=0.019, RR=1.93 (1.14–3.28), p=0.015, respectively). In SLE patients, the number of atherosclerotic plaques was associated with age (p<0.001), smoking (p=0.016), hypertension (p=0.029), and cumulative corticosteroid dose (p=0.007).ConclusionThe relative risk of subclinical atherosclerosis in SLE was comparable to that found in RA and DM, indicating that SLE patients merit a similar diligence in CVD risk assessment and management measures.
http://ift.tt/2k677Xo
Αρχειοθήκη ιστολογίου
-
►
2023
(256)
- ► Φεβρουαρίου (140)
- ► Ιανουαρίου (116)
-
►
2022
(1695)
- ► Δεκεμβρίου (78)
- ► Σεπτεμβρίου (142)
- ► Φεβρουαρίου (155)
-
►
2021
(5507)
- ► Δεκεμβρίου (139)
- ► Σεπτεμβρίου (333)
- ► Φεβρουαρίου (628)
-
►
2020
(1810)
- ► Δεκεμβρίου (544)
- ► Σεπτεμβρίου (32)
- ► Φεβρουαρίου (28)
-
►
2019
(7684)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (53)
- ► Φεβρουαρίου (2841)
- ► Ιανουαρίου (2803)
-
►
2018
(31838)
- ► Δεκεμβρίου (2810)
- ► Σεπτεμβρίου (2870)
- ► Φεβρουαρίου (2420)
- ► Ιανουαρίου (2395)
-
▼
2017
(31987)
- ► Δεκεμβρίου (2460)
- ► Σεπτεμβρίου (2605)
- ► Φεβρουαρίου (2785)
-
▼
Ιανουαρίου
(2830)
-
▼
Ιαν 29
(23)
- Longitudinal Study of Pediatric Urticaria Pigmentosa
- Use of Phototherapy in Children
- Issue Information
- Updates in wound healing: Mechanisms and translation
- 6th Conference of the European Hidradenitis Suppur...
- Clinical Snippets
- Photodynamic therapy with intradermal application ...
- Dapsone and sulfasalazine combination therapy in d...
- Idiopathic Pulmonary Hemosiderosis in a Child with...
- The effects of hydroporation on melasma with anti-...
- Acne RA-1,2, a novel UV-selective face cream for p...
- Eosinophilic Angiocentric Fibrosis as a Stenosing ...
- Lichen myxedematosus: toward established classific...
- Quantitative computed tomography imaging-based clu...
- Role of high flow nasal oxygen in the management o...
- Cervical plexus block for perioperative analgesia ...
- Pharmacokinetics and pharmacodynamics of cisatracu...
- Effects of stylet use during tracheal intubation o...
- Subclinical atherosclerosis in Systemic Lupus Eryt...
- Efficacy of belimumab on renal outcomes in patient...
- Clinical follow-up predictors of disease pattern c...
- The dangerous liaison between pollens and pollutio...
- Assessment of sleep disturbance in children with a...
-
▼
Ιαν 29
(23)
-
►
2016
(5308)
- ► Δεκεμβρίου (2118)
- ► Σεπτεμβρίου (877)
- ► Φεβρουαρίου (41)
- ► Ιανουαρίου (39)
Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174
Κυριακή 29 Ιανουαρίου 2017
Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid arthritis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου